CRMD · Company research
CorMedix Inc. (CRMD): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market - Stocktwits | CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| CRMD vs. PRTA: Which Stock Should Value Investors Buy Now? - Yahoo Finance | CRMD vs. PRTA: Which Stock Should Value Investors Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 8, 2026 | neutral | 0 | 0.6 |
| CRMD vs. PRTA: Which Stock Should Value Investors Buy Now? | In a comparison of two medical-biomedical stocks, CorMedix (CRMD) emerges as the superior value option over Prothena (PRTA). CRMD holds a Zacks Rank of #2 (Buy) with a Value grade of A, featuring a forward P/E of 13.48 and PEG ratio of 1.35. PRTA, ranked #3 (Hold) with a Value grade of F, has a forward P/E of 66.51 and PEG ratio of 1.99, indicating it is significantly more expensive relative to its growth prospects. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | neutral | 0 | 1 |
| CorMedix Inc. (CRMD) Slides 3.10% as Shares Trade Near $7.19 - Last Point Support - https://www.siam.in/ | CorMedix Inc. (CRMD) Slides 3.10% as Shares Trade Near $7.19 - Last Point Support https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 4, 2026 | neutral | 0 | 0.6 |
| CorMedix Inc (NASDAQ:CRMD) Stock Now Rated "Moderate Buy" by Wall Street Analysts - MarketBeat | CorMedix Inc (NASDAQ:CRMD) Stock Now Rated "Moderate Buy" by Wall Street Analysts MarketBeat | View source ↗ | MarketBeat | Oct 3, 2026 | neutral | 0 | 0.6 |
| CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill | CRMD News | CORMEDIX INC (NASDAQ:CRMD) ChartMill | View source ↗ | ChartMill | Sep 19, 2026 | neutral | 0 | 0.6 |
| CorMedix (CRMD) Upgraded to Buy: Here's Why - Yahoo Finance | CorMedix (CRMD) Upgraded to Buy: Here's Why Yahoo Finance | View source ↗ | Yahoo Finance | Aug 31, 2026 | neutral | 0 | 0.6 |
| CRMD Stock Up as Q2 Earnings & Sales Beat on DefenCath, Melinta Gains - Yahoo Finance | CRMD Stock Up as Q2 Earnings & Sales Beat on DefenCath, Melinta Gains Yahoo Finance | View source ↗ | Yahoo Finance | Aug 14, 2026 | neutral | 0 | 0.6 |
| CorMedix (CRMD) Stock Drops As Raised Outlook Fails To Soothe Risk Concerns - Simply Wall Street | CorMedix (CRMD) Stock Drops As Raised Outlook Fails To Soothe Risk Concerns Simply Wall Street | View source ↗ | Simply Wall Street | Aug 14, 2026 | neutral | 0 | 0.6 |
| CorMedix Stock Jumps on Strong DefenCath Sales - Cormedix (NASDAQ:CRMD) - Benzinga | CorMedix Stock Jumps on Strong DefenCath Sales - Cormedix (NASDAQ:CRMD) Benzinga | View source ↗ | Benzinga | Aug 13, 2026 | neutral | 0 | 0.6 |
| Is CRMD Stock a Buy Now After Strong Growth and New Risks? - Zacks Investment Research | Is CRMD Stock a Buy Now After Strong Growth and New Risks? Zacks Investment Research | View source ↗ | Zacks Investment Research | Jun 30, 2026 | neutral | 0 | 0.6 |
| CRMD Forecast — Price Target — Prediction for 2027 - TradingView | CRMD Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| CorMedix (CRMD) Stock Could Be 27.8% Undervalued After Q1 Results And Raised Outlook - Yahoo Finance | CorMedix (CRMD) Stock Could Be 27.8% Undervalued After Q1 Results And Raised Outlook Yahoo Finance | View source ↗ | Yahoo Finance | Jun 17, 2026 | neutral | 0 | 0.6 |
| CRMD Stock Soared 18% Today – Here’s What Fueled CorMedix’s Triple-Digit Q1 Revenue Surge - Stocktwits | CRMD Stock Soared 18% Today – Here’s What Fueled CorMedix’s Triple-Digit Q1 Revenue Surge Stocktwits | View source ↗ | Stocktwits | May 14, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.